Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-06-23

Clinical Trial Update: Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Bicifadine for chronic low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bicifadine (bicifadine)

Snippet

Sponsor: DOV Pharmaceutical, Inc. | Conditions: Chronic Low Back Pain | Phase 3 | Status: COMPLETED